CB
Cyrus Biotechnology, Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$1.5Msold at filing
Total offering$3M$1.5M still open
Investors in the raise17count reported to the SEC
FiledMay 8, 2026first sale Jul 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Chad WaiteDirector
Yifan SongDirector
Jason SmithDirector
Mark BenjaminExecutive Officer
Lucas NivonExecutive Officer, Director
Anthony ManningDirector
Ramakrishna SatyavoluDirector
Executive officers, directors and promoters as listed on the Form D.